Archives

PIK3R2

Gene:

PIK3R2

Full Name:

phosphoinositide-3-kinase, regulatory subunit 2 (beta) [Homo sapiens]

Other Symbols:

P85B, p85, p85-BETA

Other Names:

phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta); phosphoinositide-3-kinase, regulatory subunit 2 (p85 beta); phosphoinositide-3-kinase, regulatory subunit, polypeptide 2 (p85 beta)

Chromosome Location:

19q13.2-q13.4

OMIMID:

603157

GeneID:

5296

Sequences:

Nucleotide
Protein

Human-Influenza Interactions:

The influenza A NS1 protein interacts with the p85beta, [...]

MAPK14

Gene:

MAPK14

Full Name:

mitogen-activated protein kinase 14 [Homo sapiens]

Other Symbols:

RP1-179N16.5, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA

Other Names:

Csaids binding protein; MAP kinase Mxi2; MAX-interacting protein 2; cytokine suppressive anti-inflammatory drug binding protein; p38 MAP kinase; p38 mitogen activated protein kinase; p38alpha Exip; stress-activated protein kinase 2A

Chromosome [...]

Host-Virus (Human-Influenza) Interaction Genes: DEFA1

Symbol:

DEFA1

Full Name:

defensin, alpha 1 [Homo sapiens]

Other Symbols:

DEF1, DEFA2, HNP-1, HP-1, MGC138393, MRS

Other Names:

OTTHUMP00000196017; defensin, alpha 1, myeloid-related sequence; defensin, alpha 2; myeloid-related sequence

Chromosome Location:

8p23.1

OMIMID:

125220

GeneID:

1667

Sequences:

Nucleotide
Protein

Family:

Defensins

Function:

Involved in phagocyte-mediated host defense.

Pathways:

Influenza virus replication.

Human-Influenza Interactions:

Inhibited influenza virus replication, viral protein synthesis.

(http://www.ncbi.nlm.nih.gov/pubmed/17703413)

Copyright © 2009 PharmTao.com. All Rights Reserved.
Disclaimer: By using this site, the readers agree that the content on our web pages is for information purpose only. The information provided on our web pages is not intended for diagnosis, or to treat, cure or prevent any diseases, conditions or symptoms, or to do experiments, or to endorse any products. Personal directions and the use of health and biomedical products should be provided by qualified health professionals.